Gastrointestinal endoscopy
-
Gastrointest. Endosc. · Sep 2018
Randomized Controlled Trial Comparative StudyA phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.
Remimazolam is an ultrashort-acting benzodiazepine. ⋯ Remimazolam can be administered safely under the supervision of endoscopists for outpatient colonoscopy, and it allows faster recovery of neuropsychiatric function compared with placebo (midazolam rescue) and midazolam. (Clinical trial registration number: NCT02290873.).